ID:WNT3A_HUMAN DESCRIPTION: RecName: Full=Protein Wnt-3a; Flags: Precursor; FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Wnt-3 and Wnt-3a play distinct roles in cell-cell signaling during morphogenesis of the developing neural tube. SUBUNIT: Homooligomer; disulfide-linked, leading to inactivation (By similarity). Interacts with PORCN. Interacts with APCDD1 and WLS. Component of the Wnt-Fzd-LRP5-LRP6 signaling complex that contains a WNT protein, a FZD protein and LRP5 or LRP6. Interacts directly in the complex with LRP6. INTERACTION: Q9H461:FZD8; NbExp=2; IntAct=EBI-6173037, EBI-6254212; SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix. TISSUE SPECIFICITY: Moderately expressed in placenta and at low levels in adult lung, spleen, and prostate. PTM: Palmitoylation at Ser-209 is required for efficient binding to frizzled receptors. It is also required for subsequent palmitoylation at Cys-77. Palmitoylation is required for proper trafficking to cell surface, vacuolar acidification is critical to release palmitoylated WNT3A from WLS in secretory vesicles. PTM: Proteolytic processing by TIKI1 and TIKI2 promotes oxidation and formation of large disulfide-bond oligomers, leading to inactivation of WNT3A. SIMILARITY: Belongs to the Wnt family.
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P56704
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
AK056278 - Homo sapiens cDNA FLJ31716 fis, clone NT2RI2006565, highly similar to WNT-3A PROTEIN PRECURSOR. FW415998 - NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF. JA824506 - Sequence 1615 from Patent EP2471920. BC103921 - Homo sapiens wingless-type MMTV integration site family, member 3A, mRNA (cDNA clone MGC:119418 IMAGE:40007188), complete cds. BC103922 - Homo sapiens wingless-type MMTV integration site family, member 3A, mRNA (cDNA clone MGC:119419 IMAGE:40007189), complete cds. BC103923 - Homo sapiens wingless-type MMTV integration site family, member 3A, mRNA (cDNA clone MGC:119420 IMAGE:40007191), complete cds. AB060284 - Homo sapiens mRNA for WNT3A, complete cds. KJ903528 - Synthetic construct Homo sapiens clone ccsbBroadEn_12922 WNT3A gene, encodes complete protein. JD389357 - Sequence 370381 from Patent EP1572962. JD300027 - Sequence 281051 from Patent EP1572962. JD217667 - Sequence 198691 from Patent EP1572962. JD254011 - Sequence 235035 from Patent EP1572962. JD088353 - Sequence 69377 from Patent EP1572962. JD473009 - Sequence 454033 from Patent EP1572962. JD423348 - Sequence 404372 from Patent EP1572962. JD397454 - Sequence 378478 from Patent EP1572962. JD207097 - Sequence 188121 from Patent EP1572962. JD342623 - Sequence 323647 from Patent EP1572962. JD165182 - Sequence 146206 from Patent EP1572962. JD163310 - Sequence 144334 from Patent EP1572962. JD268856 - Sequence 249880 from Patent EP1572962. JD160053 - Sequence 141077 from Patent EP1572962. JD306622 - Sequence 287646 from Patent EP1572962. JD357628 - Sequence 338652 from Patent EP1572962. JD054915 - Sequence 35939 from Patent EP1572962. JD076304 - Sequence 57328 from Patent EP1572962. JD195080 - Sequence 176104 from Patent EP1572962. JD136739 - Sequence 117763 from Patent EP1572962. JD521312 - Sequence 502336 from Patent EP1572962. JD478795 - Sequence 459819 from Patent EP1572962. JD415316 - Sequence 396340 from Patent EP1572962. JD325208 - Sequence 306232 from Patent EP1572962. JD537947 - Sequence 518971 from Patent EP1572962. JD402891 - Sequence 383915 from Patent EP1572962. JD415782 - Sequence 396806 from Patent EP1572962. JD185481 - Sequence 166505 from Patent EP1572962. JD254028 - Sequence 235052 from Patent EP1572962. JD161178 - Sequence 142202 from Patent EP1572962. JD389283 - Sequence 370307 from Patent EP1572962. JD127663 - Sequence 108687 from Patent EP1572962. JD078629 - Sequence 59653 from Patent EP1572962. JD115015 - Sequence 96039 from Patent EP1572962. JD214770 - Sequence 195794 from Patent EP1572962. JD336501 - Sequence 317525 from Patent EP1572962. JD461512 - Sequence 442536 from Patent EP1572962.
Biochemical and Signaling Pathways
Reactome (by CSHL, EBI, and GO)
Protein P56704 (Reactome details) participates in the following event(s):
R-HSA-3772441 sFRP binds WNT3A and inhibits WNT:FZD binding R-HSA-201708 Frizzled receptors bind Wnts R-HSA-3238694 PORCN palmitoleoylates N-glycosyl WNTs R-HSA-4641249 ZNRF3,RNF43 binds the FZD:LRP5/6 receptor complex R-HSA-4641236 USP8 deubiquitinates FZD to potentiate WNT signaling R-HSA-4641253 ZNRF3 ubiquitinates FZD to promote its downregulation R-HSA-1458875 WNT binds to FZD and LRP5/6 R-HSA-3247843 secretion of WNT ligands R-HSA-3769370 WIF1 binds WNTs R-HSA-5323545 Canonical WNT signaling through the atypical receptor RYK R-HSA-3247840 WLS binds WNT ligands in the Golgi R-HSA-1504188 FZD recruits DVL to the receptor complex R-HSA-201691 Phosphorylation of LRP5/6 cytoplasmic domain by CSNKI R-NUL-1458902 frog CK1gamma phosphorylates LRP5/6 R-HSA-201677 Phosphorylation of LRP5/6 cytoplasmic domain by membrane-associated GSK3beta R-HSA-1504186 DVL recruits GSK3beta:AXIN1 to the receptor complex R-HSA-3772470 Negative regulation of TCF-dependent signaling by WNT ligand antagonists R-HSA-373080 Class B/2 (Secretin family receptors) R-HSA-3238698 WNT ligand biogenesis and trafficking R-HSA-4641263 Regulation of FZD by ubiquitination R-HSA-5340588 RNF mutants show enhanced WNT signaling and proliferation R-HSA-4641262 Disassembly of the destruction complex and recruitment of AXIN to the membrane R-HSA-201681 TCF dependent signaling in response to WNT R-HSA-500792 GPCR ligand binding R-HSA-195721 Signaling by WNT R-HSA-4791275 Signaling by WNT in cancer R-HSA-372790 Signaling by GPCR R-HSA-162582 Signal Transduction R-HSA-5663202 Diseases of signal transduction R-HSA-1643685 Disease